Login / Signup

Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis.

Toshihiko ArizumiSusumu TazumaHiroyuki IsayamaTakahiro NakazawaToshio TsuyuguchiHajime TakikawaAtsushi Tanakanull null
Published in: Journal of gastroenterology (2022)
In this Japanese PSC cohort, UDCA treatment was significantly associated with improved LT-free survival.
Keyphrases
  • free survival
  • combination therapy